Previous studies have demonstrated PON2 is a critical antioxidant enzyme, as the loss of PON2 is associated with multiple morbidities in-vivo, such as atherosclerosis [5, 10], heart failure [11], impaired insulin signaling [12, 13], and obesity [14]. The gene discussed is PON2; the disease is obesity disorder.